Claudio Ingold Email & Phone Number

Madrid Area, Spain

Responsible for the implementation of the “Transparency” Project in Spain, leading a multidisciplinary team to design the reporting of transfers of value issued to Health Care Professionals and Health Care Organizations. The Project included the review and improvement of internal processes to comply with the ethical and legal standards of the company. Final responsible for change management.Responsible of Marketing Excellence, including the coordination of the Annual Brand Plan with the Marketing Teams and implementation of training and motivational activities for the Teams.Participation in the design of a new Business Structure based in Franchise Teams for the Marketing and Sales areas in Roche Spain.

Leading a team of 50+ members in marketing and sales, responsible for the development of the HER2 Franchise business in Roche: Herceptin, Perjeta y Kadcyla, with yearly sales over 180 mio€.Herceptin achieves market shares over 95% consolidating as the first product in sales for the company.Successful premarketing for Perjeta and Kadcyla focused in awareness and market access activities, allowing access for the treatment of a large number of patients through early access programs and paving the way for a fast penetration of both products after launch.Member of the HER2 International Management Team and the International Biosimilar Task Force, focused in developing strategies anticipating the launch of biosimilars for Herceptin and Mabthera in Europe.

Responsible for the Marketing Teams of the Signaling Franchise (oncology products with biomarkers), including: HER2 – Herceptin (trastuzumab / breast and gastric cancer), Perjeta (pertuzumab / breast cancer) and Kadcyla (TDM-1 / breast cancer); Tarceva (erlotinib / lung and pancreatic cancer); Zelboraf (vemurafenib / melanoma); Erivedge (vismodegib / advanced vasocelular carcinoma).

Transferred to Roche Spain where I joined as responsible for the Anaemia business: NeoRecormon (epo-beta) and Mircera (peg-epo beta). Leadership of a team composed of 30+ members for marketing and sales. This team was newly created under my responsibility. For NeoRecormon two teams were created for the areas of nephrology and oncology.Limited differentiated market where NeoRecormon achieved a leadership position, reaching the #1 sales position in Roche Spain. Premarketing and launch of Mircera in renal, achieving a high market penetration.Between February 2010 and August 2010:After a team reorganization in Roche eliminating Business Unit Managers positions, I am appointed as responsible for the marketing teams for Anaemia (NeoRecormon and Mircera) and Transplants (Cellcept and Valcyte).

Leadership of the marketing team for all Rx products at Roche Uruguay.Member of the Pharma Committee and team that led the integration of Boerhinger Mannheim.From 1980 to 1989, various positions held in Roche Uruguay:Administrative AssistantStandard Costing AnalystSystems AnalystSales RepMarketing trainee (in Roche Argentina)

Licenciado, Economía

Activities and Societies: Club de Dirigentes de Marketing

Leadership